952 related articles for article (PubMed ID: 16412148)
1. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
2. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
[TBL] [Abstract][Full Text] [Related]
3. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
5. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
6. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
7. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
8. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma.
Sato Y; Itoh H; Suzuki Y; Tatsuta R; Takeyama M
J Clin Pharm Ther; 2013 Feb; 38(1):19-23. PubMed ID: 23030252
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
11. The Sinus, Allergy and Migraine Study (SAMS).
Eross E; Dodick D; Eross M
Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
[TBL] [Abstract][Full Text] [Related]
12. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
Durham PL; Cady R; Cady R
Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
[TBL] [Abstract][Full Text] [Related]
13. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Goadsby PJ; Edvinsson L
Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation.
Goadsby PJ; Edvinsson L
Cephalalgia; 1996 Oct; 16(6):448-50. PubMed ID: 8902256
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
[TBL] [Abstract][Full Text] [Related]
16. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
17. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
[TBL] [Abstract][Full Text] [Related]
19. The trigemino-vascular system and migraine.
Buzzi MG; Moskowitz MA
Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
[TBL] [Abstract][Full Text] [Related]
20. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers.
Dawidson I; Angmar-Mânsson B; Blom M; Theodorsson E; Lundeberg T
Neuropeptides; 1999 Jun; 33(3):244-50. PubMed ID: 10657499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]